GRE-21368-77292
3 vaccinations
5 coded responses
39 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 229 / VA
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-31
Registered in v-safe
-
2020-12-31
Dose 1 — Moderna
-
2020-12-31
Survey response — day 0, dose 1MedDRA: Migraine — Feeling: Fair · Site: Pain · HeadacheFree text: Headache more of migraineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-01
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-01
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-02
Survey response — days 1–6 daily, dose 1MedDRA: Skin warm, Tenderness — Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Tenderness, hot to touchMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-02
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-03
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-01-06
- 2021-01-07
-
2021-01-14
Survey response — day 14, dose 1MedDRA: Injection site erythema, Injection site pain, Injection site swelling, Injection site warmth — Feeling: GoodFree text: Redness, tenderness, hot to touch and hardness at injection site lasting for about 36-48 hours starting about 8-9 days after getting vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-21
- 2021-01-28
-
2021-01-29
Dose 2 — Moderna
-
2021-01-29
Survey response — day 0, dose 2MedDRA: Migraine — Feeling: Fair · Headache, Muscle or body achesFree text: MigraineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-31
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Chills, Headache, Muscle or body aches, NauseaAdult check-in
-
2021-02-01
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling, Itching · Headache, Fatigue or tirednessAdult check-in
-
2021-02-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Itching · Headache, Fatigue or tirednessAdult check-in
-
2021-02-03
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Headache, NauseaAdult check-in
- 2021-02-04
- 2021-02-05
- 2021-02-12
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-04-30
- 2021-08-01
-
2022-01-20
Dose 3 — Moderna
-
2022-01-20
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain, Itching · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-21
Survey response — days 1–6 daily, dose 3MedDRA: Foetal hypokinesia — Feeling: Fair · Site: Pain, Redness, Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Decreased fetal movementMedDRA releases: 2024-11 · check-in free text available
-
2022-01-22
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Itching · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-23
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-24
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Itching · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-01-26
- 2022-01-29
- 2022-02-03
- 2022-02-11
- 2022-02-17
- 2022-02-26
- 2022-03-03
- 2022-04-21
- 2022-07-21
- 2023-01-20
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Moderna | |
| 2 | 2021-01-29 | Moderna | |
| 3 | 2022-01-20 | Moderna | No |
Call center
2 call center cases
2 priority 2/3 (triaged and no follow up)
Free text
Release 1 — day 0, dose 1
Systemic reaction (other): Headache more of migraine
Release 1 — days 1–6 daily, dose 1
Systemic reaction (other): Tenderness, hot to touch
Release 2 — day 14, dose 1
Symptoms: Redness, tenderness, hot to touch and hardness at injection site lasting for about 36-48 hours starting about 8-9 days after getting vaccine
Release 3 — day 0, dose 2
Systemic reaction (other): Migraine
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Decreased fetal movement
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pain | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Injection site warmth | ✓ | ✓ | ✓ |
| SRO | Feeling hot | ○ | ○ | ○ |
| SRO | Foetal hypokinesia | · | · | ✓ |
| SRO | Migraine | ✓ | ✓ | ✓ |
| SRO | Skin warm | ✓ | ✓ | ✓ |
| SRO | Tenderness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release